Presentation of the first model to predict response to CAR T-cell therapy in multiple myeloma
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer1
An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this cancer1
The hospital stands out with five services in first place: Digestive System, General and Digestive Surgery, Haematology, Nephrology, and Radiodiagno1
There are still many questions surrounding lymphoma, its differences with leukemia and, above all, its treatment.
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
Following dietary recommendations, taking vitamin K regularly and treatment with an anticoagulant, such as Sintrom (acenocoumarol), are all important1
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
The call for the presentation of applications for the I Estella Matutes Extraordinary Scholarship is open from September 19th to November 30th.
Despite being closely related to the digestive system, Inflammatory Bowel Disease (IBD) can affect other parts of the body such as the joints, skin a1
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1